Moderna Inc.
James M Mock (Chief Financial Officer) reports MRNA insider transactions
About this filing
Moderna Inc. (MRNA) filed Form 4 (insider transaction) with the SEC on Oct 7, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- James M Mock · Chief Financial Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +1,454 | — | — | 60,829 | Direct |
| Oct 5, 2026 | F · tax withholdingFootnotes F2 | −704 | $190.01 | $133,767.04 | 60,125 | Direct |
| Oct 5, 2026 | M · exercise or conversion of a derivativeRestricted Stock UnitsFootnotes F1, F3 | −1,454 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 Restricted stock units convert into common stock on a one-for-one basis.
- F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- F3 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
More MRNA filings
- SC 13G/A
Filed Nov 5, 2026
- 4
Filed Oct 16, 2026
- 144
Filed Oct 15, 2026
- 144
Filed Oct 14, 2026
- 3
Filed Oct 5, 2026
- 8-K
Filed Sep 30, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.